This study is testing a new medicine called PF-08634404 and how it works in adults with advanced Renal Cell Carcinoma (RCC)- a type of kidney cancer that is ei…

Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more

~Estimated

~$10 – $7,500

PfizerNCT07227415

Phase 2

GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC all-risk frontline metastatic renal cell carcinoma (mRCC) patients OR any line mRCC …

Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more

~Estimated

~$10 – $6,250

Fox Chase Cancer CenterNCT05263050